Latest Industry Updates
From company milestones to industry breakthroughs, uncover the stories making waves and shaping the narrative in real time.
- Featured Article
In the fifth and final part of this video interview series, Ken Getz, executive director and...
Source: Applied Clinical Trials
- Featured Article
In part 4 of this video interview series, Ken Getz, executive director and research professor, Tufts...
Source: Applied Clinical Trials
- Featured Article
In part 3 of this video interview series, Ken Getz, executive director and research professor, Tufts...
Source: Applied Clinical Trials
- Featured Article
In part 2 of this video interview series, Ken Getz, executive director and research professor, Tufts...
Source: Applied Clinical Trials
- Featured Article
In part 1 of this video interview series with Ken Getz, executive director and research professor,...
Source: Applied Clinical Trials
- Featured Article
We are at a tipping point in the adoption of Clinical Research 2.0. The evolution of...
Source: PM360
- Press Release
King of Prussia, PA – March 25, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...
- Press Release
King of Prussia, PA: A comprehensive assessment of risk-based quality management (RBQM) adoption has revealed that...
- Press Release
King of Prussia, PA – March 5, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...
- Featured Article
In an interview with ACT editor Andy Studna at SCOPE, Young, Chief Science Officer, CluePoints discusses...
Source: Applied Clinical Trials
- Featured Article
Central monitoring aims at improving the quality of clinical research by pro-actively identifying risks and remediating...
Source: Springer Link
- Press Release
King of Prussia, PA – February 6, 2024: CluePoints, providers of best-in-class statistical and AI-driven software...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) and Data Quality Oversight solutions...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Risk-Based Monitoring (RBM) solutions for clinical trials, has...
- Press Release
We’re thrilled to announce that CluePoints’ latest version (1.9.0) of the Central Monitoring platform is live!...
- Press Release
The ASA Biopharmaceutical Section Regulatory-Industry Statistics Workshop is fast approaching and we’re thrilled to announce that...
- Press Release
Today, we’re thrilled to unveil CluePoints’ latest release of its award-winning Risk-Based Monitoring Software. For this...
- Press Release
Join CluePoints CEO Francois Torche and OmniComm Sr. Director Steve Young at this special thought leadership...
- Press Release
Awards recognize CluePoints’ Risk-Based Monitoring solution in the ‘Best Sponsor-Focused Technological Development’ category. Cambridge, MA –...
- Press Release
Partnership will combine CluePoints’ Risk-Based Monitoring Software with Widler & Schiemann’s Consultancy Services Cambridge, MA –...
- Press Release
Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials,...
- Press Release
Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials,...
- Press Release
Cambridge, MA – CluePoints, a leading provider of Centralized Statistical Monitoring (CSM) solutions for clinical trials,...
- Press Release
Cambridge, MA – CluePoints, a leading software provider of risk-based monitoring (RBM) solutions for clinical trials,...
- Featured Article
Artificial Intelligence (AI) continues to gain momentum in the pharmaceutical sector, but can it truly deliver...
Source: Health Tech World
- Featured Article
Dr Laura Trotta gives us an insight into her role at CluePoints and shares some of...
Source: Health Tech World
- Featured Article
Sas Maheswaran discusses how artificial intelligence, data and strategic partnerships can make clinical trials more sustainable...
Source: ONdrugDelivery
- Featured Article
Andrew Cooper, CEO, CluePoints, explores how AI is transforming clinical trials, the power of a purpose-driven...
Source: European Medical Journal GOLD
- Featured Article
The monitoring of key risk indicators (KRIs) is an established form of risk control in the...
Source: Applied Clinical Trials
- Featured Article
Richard Young, Chief Strategy Officer at CluePoints, shares insights on AI and risk-based quality management (RBQM)...
Source: The Clinical Trial Vanguard
- Featured Article
The pharmaceutical industry is poised for a transformative evolution by 2025, driven by the possibilities of...
Source: PM360
- Featured Article
Central monitoring is highly effective in detecting emerging quality issues in clinical trials, but debate continues...
Source: Applied Clinical Trials
- Featured Article
An essential component of risk-based quality management (RBQM), as detailed in both the ICH E8 (R1)...
Source: Applied Clinical Trials
- Featured Article
The need to boost education, shift culture, and embrace new technologies.
...Source: Applied Clinical Trials
- Featured Article
As an industry, we regularly discuss the benefits of adopting risk-based quality management (RBQM). The good...
Source: International Clinical Trials/European Pharmaceutical Contractors
- Featured Article
François Torche dispels the myth that, at least in RBQM, there is such a thing as...
Source: PM360
